Barclays PLC lowered its position in shares of Helmerich & Payne, Inc. (NYSE:HP - Free Report) by 10.8% during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 177,032 shares of the oil and gas company's stock after selling 21,383 shares during the period. Barclays PLC owned about 0.18% of Helmerich & Payne worth $5,668,000 at the end of the most recent reporting period.
Other institutional investors and hedge funds also recently made changes to their positions in the company. Summit Investment Advisors Inc. lifted its holdings in shares of Helmerich & Payne by 4.1% in the 4th quarter. Summit Investment Advisors Inc. now owns 10,113 shares of the oil and gas company's stock worth $324,000 after purchasing an additional 395 shares in the last quarter. LPL Financial LLC increased its stake in shares of Helmerich & Payne by 1.9% during the 4th quarter. LPL Financial LLC now owns 21,763 shares of the oil and gas company's stock worth $697,000 after purchasing an additional 408 shares during the last quarter. Napatree Capital LLC grew its stake in shares of Helmerich & Payne by 2.5% during the 4th quarter. Napatree Capital LLC now owns 20,847 shares of the oil and gas company's stock worth $668,000 after acquiring an additional 511 shares during the period. Franklin Resources Inc. lifted its stake in shares of Helmerich & Payne by 0.4% during the 3rd quarter. Franklin Resources Inc. now owns 157,568 shares of the oil and gas company's stock valued at $4,793,000 after buying an additional 666 shares in the last quarter. Finally, Kestra Investment Management LLC purchased a new stake in Helmerich & Payne during the 4th quarter worth about $27,000. Institutional investors and hedge funds own 96.05% of the company's stock.
Wall Street Analyst Weigh In
A number of brokerages have recently issued reports on HP. Susquehanna dropped their price target on Helmerich & Payne from $43.00 to $28.00 and set a "positive" rating for the company in a research report on Monday, April 14th. Morgan Stanley reissued an "underweight" rating and issued a $27.00 target price on shares of Helmerich & Payne in a research note on Thursday, March 27th. The Goldman Sachs Group cut their price target on shares of Helmerich & Payne from $32.00 to $25.00 and set a "sell" rating on the stock in a report on Thursday, April 10th. Evercore ISI reiterated an "in-line" rating and issued a $39.00 price objective (down from $48.00) on shares of Helmerich & Payne in a research report on Wednesday, January 15th. Finally, Barclays cut their price objective on Helmerich & Payne from $36.00 to $24.00 and set an "equal weight" rating on the stock in a research report on Wednesday, February 19th. Two research analysts have rated the stock with a sell rating, six have assigned a hold rating and three have given a buy rating to the stock. According to data from MarketBeat.com, Helmerich & Payne presently has a consensus rating of "Hold" and an average target price of $31.78.
View Our Latest Stock Report on HP
Insider Transactions at Helmerich & Payne
In related news, Director Belgacem Chariag bought 37,356 shares of the firm's stock in a transaction on Monday, February 10th. The stock was acquired at an average cost of $27.08 per share, for a total transaction of $1,011,600.48. Following the purchase, the director now owns 54,606 shares in the company, valued at approximately $1,478,730.48. This represents a 216.56 % increase in their ownership of the stock. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, CEO John W. Lindsay purchased 20,000 shares of the stock in a transaction dated Monday, February 10th. The shares were purchased at an average cost of $27.55 per share, for a total transaction of $551,000.00. Following the completion of the acquisition, the chief executive officer now directly owns 691,214 shares in the company, valued at approximately $19,042,945.70. This trade represents a 2.98 % increase in their ownership of the stock. The disclosure for this purchase can be found here. Company insiders own 4.51% of the company's stock.
Helmerich & Payne Stock Up 0.1 %
Shares of NYSE:HP traded up $0.02 during trading on Tuesday, reaching $19.84. 1,324,263 shares of the stock traded hands, compared to its average volume of 1,513,840. The stock has a market cap of $1.97 billion, a P/E ratio of 6.53, a price-to-earnings-growth ratio of 3.52 and a beta of 1.00. The company has a debt-to-equity ratio of 0.60, a quick ratio of 2.52 and a current ratio of 2.81. The stock has a 50-day moving average of $23.47 and a two-hundred day moving average of $29.77. Helmerich & Payne, Inc. has a 52-week low of $17.82 and a 52-week high of $42.60.
Helmerich & Payne (NYSE:HP - Get Free Report) last issued its earnings results on Wednesday, February 5th. The oil and gas company reported $0.71 EPS for the quarter, beating the consensus estimate of $0.69 by $0.02. Helmerich & Payne had a return on equity of 11.31% and a net margin of 11.02%. As a group, sell-side analysts expect that Helmerich & Payne, Inc. will post 2.93 earnings per share for the current fiscal year.
Helmerich & Payne Dividend Announcement
The business also recently declared a quarterly dividend, which will be paid on Friday, May 30th. Stockholders of record on Thursday, May 15th will be issued a dividend of $0.25 per share. This represents a $1.00 dividend on an annualized basis and a dividend yield of 5.04%. The ex-dividend date is Thursday, May 15th. Helmerich & Payne's payout ratio is presently 32.89%.
About Helmerich & Payne
(
Free Report)
Founded in 1920, Helmerich & Payne, Inc (H&P) NYSE: HP is committed to delivering industry leading levels of drilling productivity and reliability. H&P operates with the highest level of integrity, safety and innovation to deliver superior results for its customers and returns for shareholders.
Featured Articles

Before you consider Helmerich & Payne, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Helmerich & Payne wasn't on the list.
While Helmerich & Payne currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.